Orbion Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ORBION PHARMS, and what generic and branded alternatives to ORBION PHARMS drugs are available?
ORBION PHARMS has twenty-nine approved drugs.
Summary for Orbion Pharms
| US Patents: | 0 |
| Tradenames: | 27 |
| Ingredients: | 26 |
| NDAs: | 29 |
Drugs and US Patents for Orbion Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Orbion Pharms | DIVALPROEX SODIUM | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 078853-001 | Nov 25, 2008 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Orbion Pharms | SUMATRIPTAN SUCCINATE | sumatriptan succinate | TABLET;ORAL | 078284-003 | Aug 10, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Orbion Pharms | IBANDRONATE SODIUM | ibandronate sodium | TABLET;ORAL | 078998-001 | Mar 19, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
